September 22, 2024

Helmholtz High Impact Award 2024 presented

Helmholtz High Impact Award 2024 presented

The Helmholtz Association and the Stifterverband für die Deutsche Wissenschaft have awarded the biochemist Oliver Bruns (NCT/UCC Dresden and DKFZ) and the chemist Ellen Sletten (UCLA) with the Helmholtz High Impact Award 2024. Both are honored for their research on a new medical imaging technology in the short-wave infrared (SWIR) range, which has the potential to significantly improve the surgical removal of tumors. The scientific prize, endowed with €50,000, recognizes interdisciplinary research that addresses major challenges in science, industry, or society.

Ellen Sletten and Oliver Bruns are being recognized for an innovative method that combines short-wave infrared light with special fluorescent dyes and advanced camera technology. During surgery, individual cancer cells at tumor margins and in lymph nodes could be detected in the future. “The biggest challenge in optical imaging in humans is penetrating tissue,” says chemist Ellen Sletten. The technology she developed with her colleague Oliver Bruns overcomes this problem: “We can now create images that make different tissue types visible based on their water content. For instance, a nerve has a higher water content than fatty tissue and thus appears black,” explains Oliver Bruns. This process, known as SWIR imaging, could, in combination with special fluorescent dyes, specifically highlight certain tissues and structures, such as tumors or blood vessels. The two scientists are currently developing special dyes suitable for clinical use as contrast agents.

The scientists and their teams work at the intersection of biology, chemistry, engineering, and medicine to improve patient treatment. Their research is based at the National Center for Tumor Diseases Dresden (NCT/UCC), a joint institution of the German Cancer Research Center (DKFZ), University Hospital Carl Gustav Carus Dresden, the Faculty of Medicine of TU Dresden, and the Helmholtz-Zentrum Dresden-Rossendorf (HZDR). Oliver Bruns has led the Department of Functional Imaging in Operative Oncology at NCT/UCC Dresden since 2022. He holds a professorship at the Faculty of Medicine of TU Dresden, funded by the DKFZ. Previously, he worked at the Helmholtz Pioneer Campus in Munich, where much of the now-awarded work was developed. Ellen Sletten is a professor at the University of California, Los Angeles (UCLA) and is among the most renowned and leading chemists at her university. She is particularly known for her research on short-wave infrared dyes, which are essential for the awarded imaging method.

“The NCT was founded with the goal of rapidly and safely translating promising findings from cancer research into clinical practice. This year’s Helmholtz High Impact Award winners impressively demonstrate how close we have already come to achieving this goal,” emphasizes Otmar Wiestler, President of the Helmholtz Association. In line with the NCT’s mission to involve patients early in the research process and offer them innovative treatments as soon as possible, Oliver Bruns and Ellen Sletten, together with physicians, are currently preparing clinical trials of their new imaging technology at the NCT.

About the High Impact Award

Together with the Stifterverband für die Deutsche Wissenschaft, the Helmholtz Association is awarding the “Helmholtz High Impact Award” for the second time, after its establishment last year. The award, endowed with €50,000, recognizes highly innovative interdisciplinary contributions that address a major challenge in science, industry, or society. The scientific prize honors outstanding scientific or technically innovative achievements made in the border areas between various fields of medicine, natural, and engineering sciences, involving representatives of at least two disciplines. The focus is on new approaches that have the potential to be game changers in a relevant problem area. This year’s award ceremony took place at the Helmholtz Annual Meeting on September 17, 2024, in Berlin.

About Helmholtz
Helmholtz contributes to solving major and pressing societal, scientific, and economic challenges through scientific excellence in six research fields: Energy, Earth and Environment, Health, Information, Matter, as well as Aeronautics, Space, and Transport. With approximately 46,000 employees in 18 research centers and an annual budget exceeding 6 billion euros, Helmholtz is the largest scientific organization in Germany. Its work follows in the tradition of the great natural scientist Hermann von Helmholtz (1821-1894).

Original News

Our latest News

discover more
TSG Hoffenheim and Heidelberg University Hospital cooperate

TSG Hoffenheim and Heidelberg University Hospital cooperate

TSG Hoffenheim and Heidelberg University Hospital (UKHD) are entering into a partnership to focus more on the topic of mental health. The aim of the cooperation is to bring the Clinic for Child and Adolescent Psychiatry, the Clinic for General Psychiatry and the Sports Psychology Department of TSG closer together. More Information in German below. […]

Award-winning research in emergency medicine in Heidelberg

Award-winning research in emergency medicine in Heidelberg

Research is constantly being conducted at Heidelberg University Hospital to continuously improve patient care and patient safety. The emergency medicine department has already received several awards for its innovations and improvements. The Emergency Medicine Section of the Department of Anesthesiology at Heidelberg University Hospital (UKHD) recently received the Rudolf Frey Prize 2024 from the German […]

Psychotherapy via video in the GP practice helps with depression and anxiety

Psychotherapy via video in the GP practice helps with depression and anxiety

A new digital therapy concept provides people suffering from mental disorders with low-threshold and effective access to specialized psychosocial care. This can usefully complement existing services – as demonstrated by the PROVIDE-C study conducted by the Medical Faculty of Heidelberg University. The study was funded by the Federal Ministry of Education and Research (BMBF). Its […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp